Confirmation of double-peaked time distribution of mortality among Asian breast cancer patients in a population-based study

Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre, Singapore.
Breast cancer research: BCR (Impact Factor: 5.88). 02/2007; 9(2):R21. DOI: 10.1186/bcr1658
Source: PubMed

ABSTRACT Double-peaked time distributions of the mortality hazard function have been reported for breast cancer patients from Western populations treated with mastectomy alone. These are thought to reflect accelerated tumour growth at micrometastatic sites mediated by angiogenesis after primary tumour removal as well as tumor dormancy. Similar data are not available for Asian populations. We sought to investigate whether differences exist in the pattern of mortality hazard function between Western breast cancer patients and their Asian counterparts in Singapore, which may suggest underlying differences in tumor biology between the two populations.
We performed a retrospective cohort study of female unilateral breast cancer patients diagnosed in Singapore between October 1994 and June 1999. Data regarding patient demographics, tumour characteristics and death were available. Overall survival curves were calculated using the Kaplan-Meier method. The hazard rate was calculated as the conditional probability of dying in a time interval, given that the patient was alive at the beginning of the interval. The life table method was used to calculate the yearly hazard rates.
In the 2,105 women identified, 956 patients (45.4%) had mastectomy alone. Demographic characteristics were as follows: 86.5% were Chinese, 45.2% were postmenopausal, 38.9% were hormone receptor positive, 54.6% were node negative and 44.1% had high histological grade. We observed a double-peaked mortality hazard pattern, with a first peak in mortality achieving its maximum between years 2 and 4 after mastectomy, and a second large peak in mortality during year 9. Analyses by subgroups revealed a similar pattern regardless of T stage, or node or menopausal status. This pattern was also noted in high-grade tumors but not in those that were well to moderately differentiated. The double-peaked pattern observed in Singaporean women was quantitatively and qualitatively similar to those reported in Western series.
Our study confirms the existence of a double-peaked process in Asian patients, and it gives further support to the tumour dormancy hypothesis after mastectomy.

  • [Show abstract] [Hide abstract]
    ABSTRACT: An improved "weighted information" method of spectral estimation has recently been introduced [1,2]. The method treats the problem of estimating autoregressive (AR) process parameters from discrete time observations corrupted by additive independent noise, with known power spectral density. The estimation procedure is cast as the problem of minimizing a weighted information measure and has a theoretical foundation relating it to asymptotic maximum likelihood and minimum information divergence procedures. This paper develops several topological properties of the weighted information measure. Computational procedures appropriate to the estimation problem are discussed elsewhere [1,2]; procedures appropriate to the detection ("vector quantization") problem are presented here. Simulation results and a real speech example demonstrate the advantages of the method.
    Acoustics, Speech, and Signal Processing, IEEE International Conference on ICASSP '84.; 04/1984
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To explain bimodal relapse patterns observed in breast cancer data, we have proposed that metastatic breast cancer growth commonly includes periods of temporary dormancy at both the single cell phase and the avascular micrometastasis phase. The half-lives of these states are 1 and 2 years respectively. We also suggested that surgery to remove the primary tumor often terminates dormancy resulting in accelerated relapses. These iatrogenic events are very common in that over half of all metastatic relapses progress in that manner. Assuming this is true, there should be ample and clear evidence in clinical data. We review here the breast cancer paradigm from early detection, through treatment and follow-up, and consider how dormancy and surgery-driven escape from dormancy would be observed. We examine mammography data, effectiveness of adjuvant chemotherapy, heterogeneity and aggressiveness, timing of surgery within the menstrual cycle and racial differences in outcome. Dormancy can be identified in these diverse data but most conspicuous is the sudden escape from dormancy following primary surgery. These quantitative findings provide linkage between experimental studies of tumor dormancy and clinical efforts to improve patient outcome.
    Apmis 01/2008; 116(7-8):730-41. DOI:10.1111/j.1600-0463.2008.00990.x · 1.92 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Tumor progression is dependent on a number of sequential steps, including initial tumor-vascular interactions and recruitment of blood vessels (i.e., the angiogenic switch), as well as tumor cells interacting with the surrounding microenvironment and its different components. Failure of a microscopic tumor to complete one or more of these early stages may lead to delayed clinical manifestation of the cancer and a state of stable non-progressing disease (i.e., tumor dormancy). In this review, some of the clinical and experimental evidence is summarized, suggesting that microscopic human cancers, either primary, recurrent or metastatic, can remain in an asymptomatic, non-detectable, and occult state for a long period of time. We also review current experimental human tumor dormancy models which closely recapitulate clinically observed delay in tumor progress.
    Apmis 01/2008; 116(7-8):569-85. DOI:10.1111/j.1600-0463.2008.01213.x · 1.92 Impact Factor

Preview (3 Sources)

Available from